Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease

Movement Disorders

Volumn 19, Issue 6, 2004, Pages 705-707

  Paus, Sebastian ^a   Seeger, Gert ^b   Brecht, Hans M ^c   Köster, Jürgen ^c   El Faddagh, Mahha ^b   Nöthen, Markus M ^d   Klockgether, Thomas ^a   Wüllner, Ullrich ^a,e  

^a UNIVERSITY OF BONN   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SEROTONIN TRANSPORTER;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SOMNOLENCE; STATISTICAL ANALYSIS;

ALLELES; CARRIER PROTEINS; DISORDERS OF EXCESSIVE SOMNOLENCE; GENE EXPRESSION; GENOTYPE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 4444320076     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20134     Document Type: Article

References (11)

1. Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002;287:455-463.
2. Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U. Sleep attacks, daytime sleepiness and dopamine agonists in Parkinson's disease. Mov Disord 2003;18:659-667.
3. Olanow CW, Schapira AH, Roth T. Waking up to sleep episodes in Parkinson's disease. Mov Disord 2000;15:212-215.
4. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997;6:577-582.
5. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 1993;2:2197.
6. Rietschel M, Krauss H, Muller DJ, et al. Dopamine D3 receptor variant and tardive dyskinesia. Eur Arch Psychiatry Clin Neurosci 2000;250:31-35.
7. Serretti R, Lilli R, Lorenzi C, Lattuada E, Smeraldi E. DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects. Am J Med Genet 2001;105:283-290.
8. Rao D, Jonsson EG, Paus S, Ganguli R, Nöthen M, Nimgaonkar VL. Schizophrenia and the serotonin transporter gene. Psychiatr Genet 1998;8:207-212.
9. Ashgari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HHM. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65:1157-1165.
10. Chio CL, Drong RF, Riley DT, Gill GS, Slightom JL, Huff RT. D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J Biol Chem 1994;269:11813-11819.
11. Schoots O, Van Tol HH. The human dopamine D4 receptor repeat sequences modulate expression. Pharmacogenomics J 2003;3:343-348.